Nalgesin Pro (Naproxen Sodium)

Naproxen sodium works by non‑selectively blocking the cyclooxygenase‑1 and cyclooxygenase‑2 enzymes, which are essential for converting arachidonic acid into prostaglandins. By reducing prostaglandin production, it diminishes the inflammatory response, pain signaling, and fever generation throughout the body.

The specific dosage of Nalgesin Pro is determined by the prescribing healthcare professional based on the individual’s condition, severity, age, and renal or hepatic function. Patients should follow the prescriber’s instructions and not alter the dose without medical guidance.

Safety of naproxen sodium in pregnancy or lactation has not been definitively established. It is generally avoided in the third trimester of pregnancy due to potential fetal risks, and caution is advised during breastfeeding because the drug can be excreted in milk. Consultation with a healthcare provider is essential before use.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements), and necessary import documentation.

Naproxen sodium, the active ingredient in Nalgesin Pro, has a longer half‑life than ibuprofen, allowing less frequent dosing for chronic conditions. Compared with selective COX‑2 inhibitors, it is non‑selective and may carry a higher gastrointestinal risk but has a lower cardiovascular risk profile. Choice depends on patient‑specific factors and therapeutic goals.

Nalgesin Pro should be stored at ambient temperature, preferably below 25 °C. Keep the tablets in their original blister or bottle, protect them from moisture, heat, and direct sunlight, and ensure the container is tightly closed to maintain product stability.

Nalgesin Pro is taken orally with a full glass of water. It may be taken with or without food, although taking it with food can reduce gastrointestinal discomfort. Patients should swallow the tablet whole and not crush or chew it unless specifically instructed by a healthcare professional.

The most serious risks include gastrointestinal ulceration or bleeding, cardiovascular events such as heart attack or stroke, acute kidney injury, severe skin reactions like Stevens‑Johnson syndrome, and anaphylactic reactions. Patients should seek immediate medical attention if they experience symptoms such as severe abdominal pain, black stools, chest pain, shortness of breath, or rash.

Nalgesin Pro is contraindicated in individuals with a known hypersensitivity to naproxen or other NSAIDs, those with active gastrointestinal bleeding or ulcer disease, severe heart failure, and patients who have had a recent coronary artery bypass graft. It should also be avoided in the third trimester of pregnancy and used with caution in patients with renal or hepatic impairment.